Can myomectomy be suggested for perimenopausal women before administering hormone replacement therapy?

Marta Gavai, Eniko Berkes, Zoltan F. Takacs, Z. Papp

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives: The aim of this study was to evaluate whether abdominal myomectomy could be a choice for patients with symptomatic fibroids above the age of 48 years, who wish to get hormonal replacement therapy and desire to retain their uterus. Methods: We performed 504 abdominal myomectomies between 1990 and 2004. The mean age was 33 ± 4.09 years, 9 (1.8%; 9/504) patients were above 48 years and 6 (1.19%; 6/504) of them requested hormonal replacement therapy (HRT) after the enucleation of fibroids. Data of these nine cases were compared to a matched control group of patients who had hysterectomy in the same year in 3 months to those who underwent abdominal myomectomy with same indications for surgery, same location, size and number of fibroids. The main aim of our study was to compare perioperative morbidity, duration of hospital stay between myomectomy and hysterectomy groups and determine the recurrence of fibroids and/or symptoms in 1 year with HRT in the myomectomy group. Results: The perioperative morbidity did not differ between the compared groups. In the myomectomy group with 1-year HRT we did not observe the recurrence of fibroids and symptoms. Conclusion: Our data suggest that abdominal myomectomy may be a satisfactory option for perimenopausal women with symptomatic fibroids who wish to retain their uterus and get HRT.

Original languageEnglish
Pages (from-to)107-110
Number of pages4
JournalMaturitas
Volume58
Issue number1
DOIs
Publication statusPublished - Sep 20 2007

Fingerprint

Uterine Myomectomy
Hormone Replacement Therapy
Leiomyoma
Surgery
Hormones
Hysterectomy
Uterus
Morbidity
Therapeutics
Recurrence
Length of Stay
Research Design

Keywords

  • Abdominal myomectomy
  • Hormone replacement therapy
  • Hysterectomy
  • Menopause
  • Perioperative morbidity

ASJC Scopus subject areas

  • Ageing
  • Obstetrics and Gynaecology

Cite this

Can myomectomy be suggested for perimenopausal women before administering hormone replacement therapy? / Gavai, Marta; Berkes, Eniko; Takacs, Zoltan F.; Papp, Z.

In: Maturitas, Vol. 58, No. 1, 20.09.2007, p. 107-110.

Research output: Contribution to journalArticle

Gavai, Marta ; Berkes, Eniko ; Takacs, Zoltan F. ; Papp, Z. / Can myomectomy be suggested for perimenopausal women before administering hormone replacement therapy?. In: Maturitas. 2007 ; Vol. 58, No. 1. pp. 107-110.
@article{a5d8053876ca446f9c8e94120bd5a8af,
title = "Can myomectomy be suggested for perimenopausal women before administering hormone replacement therapy?",
abstract = "Objectives: The aim of this study was to evaluate whether abdominal myomectomy could be a choice for patients with symptomatic fibroids above the age of 48 years, who wish to get hormonal replacement therapy and desire to retain their uterus. Methods: We performed 504 abdominal myomectomies between 1990 and 2004. The mean age was 33 ± 4.09 years, 9 (1.8{\%}; 9/504) patients were above 48 years and 6 (1.19{\%}; 6/504) of them requested hormonal replacement therapy (HRT) after the enucleation of fibroids. Data of these nine cases were compared to a matched control group of patients who had hysterectomy in the same year in 3 months to those who underwent abdominal myomectomy with same indications for surgery, same location, size and number of fibroids. The main aim of our study was to compare perioperative morbidity, duration of hospital stay between myomectomy and hysterectomy groups and determine the recurrence of fibroids and/or symptoms in 1 year with HRT in the myomectomy group. Results: The perioperative morbidity did not differ between the compared groups. In the myomectomy group with 1-year HRT we did not observe the recurrence of fibroids and symptoms. Conclusion: Our data suggest that abdominal myomectomy may be a satisfactory option for perimenopausal women with symptomatic fibroids who wish to retain their uterus and get HRT.",
keywords = "Abdominal myomectomy, Hormone replacement therapy, Hysterectomy, Menopause, Perioperative morbidity",
author = "Marta Gavai and Eniko Berkes and Takacs, {Zoltan F.} and Z. Papp",
year = "2007",
month = "9",
day = "20",
doi = "10.1016/j.maturitas.2007.05.004",
language = "English",
volume = "58",
pages = "107--110",
journal = "Maturitas",
issn = "0378-5122",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Can myomectomy be suggested for perimenopausal women before administering hormone replacement therapy?

AU - Gavai, Marta

AU - Berkes, Eniko

AU - Takacs, Zoltan F.

AU - Papp, Z.

PY - 2007/9/20

Y1 - 2007/9/20

N2 - Objectives: The aim of this study was to evaluate whether abdominal myomectomy could be a choice for patients with symptomatic fibroids above the age of 48 years, who wish to get hormonal replacement therapy and desire to retain their uterus. Methods: We performed 504 abdominal myomectomies between 1990 and 2004. The mean age was 33 ± 4.09 years, 9 (1.8%; 9/504) patients were above 48 years and 6 (1.19%; 6/504) of them requested hormonal replacement therapy (HRT) after the enucleation of fibroids. Data of these nine cases were compared to a matched control group of patients who had hysterectomy in the same year in 3 months to those who underwent abdominal myomectomy with same indications for surgery, same location, size and number of fibroids. The main aim of our study was to compare perioperative morbidity, duration of hospital stay between myomectomy and hysterectomy groups and determine the recurrence of fibroids and/or symptoms in 1 year with HRT in the myomectomy group. Results: The perioperative morbidity did not differ between the compared groups. In the myomectomy group with 1-year HRT we did not observe the recurrence of fibroids and symptoms. Conclusion: Our data suggest that abdominal myomectomy may be a satisfactory option for perimenopausal women with symptomatic fibroids who wish to retain their uterus and get HRT.

AB - Objectives: The aim of this study was to evaluate whether abdominal myomectomy could be a choice for patients with symptomatic fibroids above the age of 48 years, who wish to get hormonal replacement therapy and desire to retain their uterus. Methods: We performed 504 abdominal myomectomies between 1990 and 2004. The mean age was 33 ± 4.09 years, 9 (1.8%; 9/504) patients were above 48 years and 6 (1.19%; 6/504) of them requested hormonal replacement therapy (HRT) after the enucleation of fibroids. Data of these nine cases were compared to a matched control group of patients who had hysterectomy in the same year in 3 months to those who underwent abdominal myomectomy with same indications for surgery, same location, size and number of fibroids. The main aim of our study was to compare perioperative morbidity, duration of hospital stay between myomectomy and hysterectomy groups and determine the recurrence of fibroids and/or symptoms in 1 year with HRT in the myomectomy group. Results: The perioperative morbidity did not differ between the compared groups. In the myomectomy group with 1-year HRT we did not observe the recurrence of fibroids and symptoms. Conclusion: Our data suggest that abdominal myomectomy may be a satisfactory option for perimenopausal women with symptomatic fibroids who wish to retain their uterus and get HRT.

KW - Abdominal myomectomy

KW - Hormone replacement therapy

KW - Hysterectomy

KW - Menopause

KW - Perioperative morbidity

UR - http://www.scopus.com/inward/record.url?scp=34547933052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547933052&partnerID=8YFLogxK

U2 - 10.1016/j.maturitas.2007.05.004

DO - 10.1016/j.maturitas.2007.05.004

M3 - Article

C2 - 17629638

AN - SCOPUS:34547933052

VL - 58

SP - 107

EP - 110

JO - Maturitas

JF - Maturitas

SN - 0378-5122

IS - 1

ER -